Head Office Oxford
CEO Dr Holly Reeve
CSO Dr Sarah Cleary
CGF Board Rep Susannah McClintock
HydRegen is pioneering the production of bio-based catalysts that enable cleaner, safer and more energy-efficient manufacturing processes for the global pharmaceutical and chemicals industries. Their innovative biotechnology aims to deliver huge COâ‚‚ savings and operating costs by replacing toxic metal catalysts with environmentally and economically friendly bio-based alternatives.
Picture credits: www.charlieflounders.com
The post HydRegen appeared first on Clean Growth Fund.
